IP Library › Assignment 047555/0568
Patent Assignment
Reel/Frame 047555/0568

Merger

Recorded: 2018-11-20 Pages: 5
Assignor
OCULARIS PHARMA, LLC
Executed: 2018-04-10
Assignee
OCUPHIRE PHARMA, INC.
6894 LAKEMONT CIRCILE, WEST BLOOMFIELD, MICHIGAN, 48323
Covered Properties (6)
Method for optimizing pupil size using alpha antagonist
Patent: 6,291,498 →
Application: 09/662,945 →
Night Vision Composition
Patent: 6,730,065 →
Application: 09/675,988 →
Ophthalmic Formulation Which Modulates Dilation
Patent: 6,420,407 →
Application: 09/710,758 →
Ophthalmic Formulation Which Modulates Dilation
Patent: 6,515,006 →
Application: 10/165,459 →
Publication: US 2002/0187986
Night Vision Composition
Patent: 8,979,809 →
Application: 10/799,299 →
Publication: US 2004/0176408
Ophthalmic formulations including selective alpha 1 antagonists
Patent: 8,889,112 →
Application: 10/867,144 →
Publication: US 2005/0080056
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 3, 2002
From: HORN, GERALD
To: HMT PHARMA, INC.
Reel/Frame 013250/0043 →
Change of Name Mar 25, 2003
From: HORN, GERALD
To: OCULARIS PHARMA, INC.
Reel/Frame 013894/0887 →
Assignment of Assignor's Interest Jun 25, 2004
From: HORN, GERALD
To: OCULARIS PHARMA, INC.
Reel/Frame 014784/0213 →
Assignment of Assignor's Interest Dec 15, 2004
From: HORN, GERALD
To: OCULARIS PHARMA, INC.
Reel/Frame 015468/0243 →
Change of Name Oct 9, 2014
From: OCULARIS PHARMA, INC.
To: OCULARIS PHARMA, LLC
Reel/Frame 033924/0243 →
Change of Name Feb 3, 2015
From: OCULARIS PHARMA, INC.
To: OCULARIS PHARMA, LLC
Reel/Frame 034873/0699 →
Assignment of Assignor's Interest Nov 19, 2018
From: OCULARIS PHARMA, INC.
To: OCULARIS PHARMA, LLC
Reel/Frame 047539/0082 →